258 related articles for article (PubMed ID: 8710773)
21. [Maternal serum screening for congenital abnormalities and Down syndrome in Sønderjylland County. Eight years of experience].
Christiansen M; Petersen PL; Permin M; Larsen LA; Nørgaard-Pedersen B
Ugeskr Laeger; 1999 Dec; 161(50):6928-34. PubMed ID: 10643380
[TBL] [Abstract][Full Text] [Related]
22. [Fetoplacental antigens in pregnancies with fetal chromosomal aberrations].
Fialová L; Malbohan I; Mikulíková L; Hájek Z
Sb Lek; 1993; 94(2):179-83. PubMed ID: 7527584
[TBL] [Abstract][Full Text] [Related]
23. Improved prenatal diagnosis of the congenital nephrotic syndrome of the Finnish type based on DNA analysis.
Männikkö M; Kestilä M; Lenkkeri U; Alakurtti H; Holmberg C; Leisti J; Salonen R; Aula P; Mustonen A; Peltonen L; Tryggvason K
Kidney Int; 1997 Mar; 51(3):868-72. PubMed ID: 9067923
[TBL] [Abstract][Full Text] [Related]
24. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
Sancken U; Bartels I
Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
[TBL] [Abstract][Full Text] [Related]
25. Amniotic alpha-fetoprotein in the prenatal diagnosis of congenital nephrotic syndrome of the Finnish type.
Morris J; Ellwood D; Kennedy D; Knight J
Prenat Diagn; 1995 May; 15(5):482-5. PubMed ID: 7543998
[TBL] [Abstract][Full Text] [Related]
26. Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.
Doran TA; Valentine GH; Wong PY; Wielgosz G; Benzie RJ; Soltan HC; Jenner MR; Morland PA; Montgomery RJ; Allen LC
CMAJ; 1987 Aug; 137(4):285-93. PubMed ID: 2440547
[TBL] [Abstract][Full Text] [Related]
27. Congenital nephrotic syndrome: clinico-pathological heterogeneity and prenatal diagnosis.
Schneller M; Braga SE; Moser H; Zimmermann A; Oetliker O
Clin Nephrol; 1983 May; 19(5):243-9. PubMed ID: 6851264
[TBL] [Abstract][Full Text] [Related]
28. Congenital and infantile nephrotic syndromes.
Norio R; Rapola J
Prog Clin Biol Res; 1989; 305():179-92. PubMed ID: 2668971
[TBL] [Abstract][Full Text] [Related]
29. [Alpha fetoprotein concentration in the amniotic fluid in normal pregnancy and in pregnancy complicated by fetal anomaly].
Szabó M; Veress L; Münnich A; Papp Z
Orv Hetil; 1990 Sep; 131(39):2139-42. PubMed ID: 1699194
[TBL] [Abstract][Full Text] [Related]
30. [Prenatal differential diagnosis in elevated alpha-fetoprotein concentration in the amniotic fluid (author's transl)].
Cremer M; Schmidt W; Voigtländer T; Rehder H
Z Geburtshilfe Perinatol; 1981 Oct; 185(5):299-304. PubMed ID: 6171938
[TBL] [Abstract][Full Text] [Related]
31. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
32. [Amniotic AFP concentration in pregnancies with numerical chromosome aberrations].
Vytiska-Binstorfer E; Genger H; Huber J
Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):732-4. PubMed ID: 2433179
[TBL] [Abstract][Full Text] [Related]
33. Role of fetal sex in amniotic fluid alphafetoprotein screening.
Knippel AJ
Prenat Diagn; 2002 Oct; 22(10):941-5. PubMed ID: 12378582
[TBL] [Abstract][Full Text] [Related]
34. A normal ultrasound does not obviate the need for amniocentesis in patients with elevated serum alpha-fetoprotein.
Drugan A; Zador IE; Syner FN; Sokol RJ; Sacks AJ; Evans MI
Obstet Gynecol; 1988 Oct; 72(4):627-30. PubMed ID: 2458560
[TBL] [Abstract][Full Text] [Related]
35. Prenatal diagnosis of neural tube defects: predictive value of AF-AFP in a low-risk population.
Fisher NL; Luthy DA; Peterson A; Karp LE; Williamson R; Cheng E
Am J Med Genet; 1981; 9(3):201-9. PubMed ID: 6169278
[TBL] [Abstract][Full Text] [Related]
36. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
[TBL] [Abstract][Full Text] [Related]
37. Prenatal trisomy 21 screening using the Lens culinaris agglutinin-reactive alpha-fetoprotein ratio.
Yamamoto R; Minobe S; Ebina Y; Watari H; Kudo M; Henmi F; Satomura S; Fujimoto S; Minakami H; Sakuragi N
Congenit Anom (Kyoto); 2004 Jun; 44(2):87-92. PubMed ID: 15198721
[TBL] [Abstract][Full Text] [Related]
38. Ultrasound-adjusted risk and spectrum of fetal chromosomal abnormality in women with elevated maternal serum alpha-fetoprotein.
Megerian G; Godmilow L; Donnenfeld AE
Obstet Gynecol; 1995 Jun; 85(6):952-6. PubMed ID: 7539525
[TBL] [Abstract][Full Text] [Related]
39. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
40. Risks for fetal abnormalities after very and moderately elevated AF-AFPs.
Crandall BF; Chua C
Prenat Diagn; 1997 Sep; 17(9):837-41. PubMed ID: 9316128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
